Actinium Pharmaceuticals Inc. macht sich auf den Weg (Seite 32)
eröffnet am 10.06.15 18:13:59 von
neuester Beitrag 02.11.23 22:50:13 von
neuester Beitrag 02.11.23 22:50:13 von
Beiträge: 480
ID: 1.213.944
ID: 1.213.944
Aufrufe heute: 0
Gesamt: 68.989
Gesamt: 68.989
Aktive User: 0
ISIN: US00507W2061 · WKN: A2QA48 · Symbol: ATNM
8,2150
EUR
+1,61 %
+0,1300 EUR
Letzter Kurs 09.05.24 Tradegate
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,2000 | +93,94 | |
| 1,0300 | +37,44 | |
| 1,3300 | +30,51 | |
| 1,9950 | +27,48 | |
| 21,010 | +26,80 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,2000 | -17,81 | |
| 7,5000 | -20,97 | |
| 2,4650 | -27,50 | |
| 4,6600 | -41,60 | |
| 2,0400 | -51,31 |
Beitrag zu dieser Diskussion schreiben
Feedbackweiter up +6.39%
Actinium Pharmaceuticals, Inc. Echtzeit-BörsenkurseATNM $2.33* +0.14 +6.39%
Antwort auf Beitrag Nr.: 50.493.978 von blue-moon am 26.08.15 17:09:46
Ist nicht lange her -
Zitat von blue-moon: Hallo,
ab und an möchte ich mal schauen was so in anderen Threads geschrieben wird.
Bei Yahoo z. B findet man eine aktuelle strong buy Empfehlung mit Ziel 50 $.
(24.08.15)
Zitat
A run from $2 to $50 is possible on a partnership/ph3 combo announcement...
Could move up to $50 in as little as 16 trading hours to 16 months.
Sentiment: Strong Buy
http://finance.yahoo.com/mbview/threadview/?&bn=b6fe301b-9a1…
Oh jetzt sogar +10%
Was ist da im Busch 
Aktuell +6%
Damit sind wir wieder deutlich über 2 also bei 2,09$ - das sieht echt gut aus! 
Info von heute:
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical firm developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium reported recently that subsequent to its pre-IND (Investigative New Drug) meeting with the U.S. Food and Drug Administration (FDA) for its Iomab-B drug candidate, the Firm is finalizing the IND filing for submission to the FDA to support the start of the Phase 3 clinical study. “We are quite happy with the outcome of our pre-IND meeting which provided valuable feedback regarding our upcoming IND submission for Iomab-B. We are close to finalizing our application package and remain on track to file the IND in the first quarter of this year, in-line with our guidance. We are optimistic that the FDA will award the filing an IND designation which will allow us to move into the critical Phase 3 stage for Iomab-B,” noted Kaushik J. Dave, Chief Executive Officer of Actinium Pharmaceuticals. “We are also continuing to establish the infrastructure necessary to enable speedy Phase 3 development of Iomab-B.”
Shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) [Trend Analysis] opened at $1.93 with 40.63 million outstanding shares and hit to its highest price of $2.05 during the day and finally closed at $1.97 by scoring 2.60%. In the whole session, it traded on volume of 307819 shares, which turned higher than its average volume.
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical firm developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium reported recently that subsequent to its pre-IND (Investigative New Drug) meeting with the U.S. Food and Drug Administration (FDA) for its Iomab-B drug candidate, the Firm is finalizing the IND filing for submission to the FDA to support the start of the Phase 3 clinical study. “We are quite happy with the outcome of our pre-IND meeting which provided valuable feedback regarding our upcoming IND submission for Iomab-B. We are close to finalizing our application package and remain on track to file the IND in the first quarter of this year, in-line with our guidance. We are optimistic that the FDA will award the filing an IND designation which will allow us to move into the critical Phase 3 stage for Iomab-B,” noted Kaushik J. Dave, Chief Executive Officer of Actinium Pharmaceuticals. “We are also continuing to establish the infrastructure necessary to enable speedy Phase 3 development of Iomab-B.”
Shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) [Trend Analysis] opened at $1.93 with 40.63 million outstanding shares and hit to its highest price of $2.05 during the day and finally closed at $1.97 by scoring 2.60%. In the whole session, it traded on volume of 307819 shares, which turned higher than its average volume.
Trading Spotlight
Wieder über 2,01 $ und damit aktuell fast + 5%
Leute das sieht sehr gut aus - wir hatten den kleinen Rücksetzer und jetzt ist der Weg frei, daher gilt für mich: strong buy 
Kommt jetzt der Ausbruch 
Heute ist wieder so ein Tag wo mein Bauch sagt - schaue dir das mal genau an.
Könnten wir bald im Kurs dramatisch ausbrechen - das Potential dazu hat die Aktie.
Könnten wir bald im Kurs dramatisch ausbrechen - das Potential dazu hat die Aktie.
+ 5,29% Schluss USA
Wie immer ist der auf WO angezeigte Kurs irre führend, daher erlaube ich mir von Zeit zu Zeit den aktuellen Kurs - oder die Veränderung hier mitzuteilen - für meine Freunde. - meine guten Freunde! 
Durchsuchen
